TrialScience advances2023

The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cells.

Anthony Lemarié et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.